Literature DB >> 16343265

Transplantation of umbilical cord blood-derived endothelial progenitor cells: a promising method of therapeutic revascularisation.

Lei Zhang1, Renchi Yang, Zhong Chao Han.   

Abstract

Therapeutic neovascularisation by endothelial progenitor cells (EPCs) mediated vascular regeneration is becoming a novel option for the treatment of ischaemic diseases. Recently, human umbilical cord blood (CB) has been found to contain a large number of EPCs and transplantation of CB EPCs led to a successful salvage of the ischaemic limbs through improvement in blood perfusion, indicating the feasibility of using CB cells for therapeutic revascularisation. This review will summarise recent studies in therapeutic revascularisation using CB cells and discuss the potential clinical utilisation of CB cells in ischaemic diseases.

Entities:  

Mesh：

Year:  2006        PMID： 16343265     DOI： 10.1111/j.1600-0609.2005.00579.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN： 0902-4441            Impact factor:   2.997


  14 in total

1.  Dynamic adhesion of umbilical cord blood endothelial progenitor cells under laminar shear stress.

Authors:  Mathew G Angelos; Melissa A Brown; Lisa L Satterwhite; Vrad W Levering; Natan T Shaked; George A Truskey
Journal:  Biophys J       Date:  2010-12-01       Impact factor: 4.033

2.  Characterization of umbilical cord blood-derived late outgrowth endothelial progenitor cells exposed to laminar shear stress.

Authors:  Melissa A Brown; Charles S Wallace; Mathew Angelos; George A Truskey
Journal:  Tissue Eng Part A       Date:  2009-11       Impact factor: 3.845

3.  Transplanted late outgrowth endothelial progenitor cells as cell therapy product for stroke.

Authors:  Chahrazad Moubarik; Benjamin Guillet; Bennis Youssef; Jean-Laurent Codaccioni; Marie-Dominique Piercecchi; Florence Sabatier; Pellegrini Lionel; Laetitia Dou; Alexandrine Foucault-Bertaud; Lionel Velly; Françoise Dignat-George; Pascale Pisano
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

4.  Human umbilical cord blood-derived endothelial cells reendothelialize vein grafts and prevent thrombosis.

Authors:  Melissa A Brown; Lisheng Zhang; Vrad W Levering; Jiao-Hui Wu; Lisa L Satterwhite; Leigh Brian; Neil J Freedman; George A Truskey
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-08-26       Impact factor: 8.311

Review 5.  Human umbilical cord blood stem cells, myocardial infarction and stroke.

Authors:  Nathan Copeland; David Harris; Mohamed A Gaballa
Journal:  Clin Med (Lond)       Date:  2009-08       Impact factor: 2.659

6.  Angiogenic potential of endothelial progenitor cells and embryonic stem cells.

Authors:  Peter C Rae; Richard Dw Kelly; Stuart Egginton; Justin C St John
Journal:  Vasc Cell       Date:  2011-05-11

7.  Deguelin inhibits vasculogenic function of endothelial progenitor cells in tumor progression and metastasis via suppression of focal adhesion.

Authors:  Minh Phuong Nguyen; Dongjin Lee; Se-Hyung Lee; Hye-Eun Lee; Ho-Young Lee; You Mie Lee
Journal:  Oncotarget       Date:  2015-06-30

8.  Histone deacetylase (HDAC) inhibitors down-regulate endothelial lineage commitment of umbilical cord blood derived endothelial progenitor cells.

Authors:  Florin Iordache; Cosmin Buzila; Andrei Constantinescu; Eugen Andrei; Horia Maniu
Journal:  Int J Mol Sci       Date:  2012-11-15       Impact factor: 5.923

9.  Rehmannia glutinosa extract activates endothelial progenitor cells in a rat model of myocardial infarction through a SDF-1 α/CXCR4 cascade.

Authors:  Ying-Bin Wang; Yun-Fang Liu; Xiao-Ting Lu; Fang-Fang Yan; Bo Wang; Wen-Wu Bai; Yu-Xia Zhao
Journal:  PLoS One       Date:  2013-01-18       Impact factor: 3.240

Review 10.  Building blood vessels--stem cell models in vascular biology.

Authors:  Lars Jakobsson; Johan Kreuger; Lena Claesson-Welsh
Journal:  J Cell Biol       Date:  2007-05-29       Impact factor: 10.539
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.